Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 63, Topic 4
In Progress

Supportive Care and Complication Prevention in Sepsis and Septic Shock

Lesson Progress
0% Complete
Supportive Care and Complication Prevention in Sepsis and Septic Shock

Supportive Care and Complication Prevention in Sepsis and Septic Shock

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Objective

Recommend appropriate supportive care and monitoring to mitigate the morbidity of sepsis and septic shock.

1. Mechanical Ventilation Strategies

Sepsis-induced Acute Respiratory Distress Syndrome (ARDS) demands timely recognition of respiratory failure and application of lung-protective ventilation to reduce ventilator-associated lung injury.

Indications for Invasive Ventilation

  • Refractory Hypoxemia: PaO₂/FiO₂ ratio ≤150 mmHg despite noninvasive support.
  • Respiratory Muscle Fatigue: Respiratory rate >35 breaths/min, use of accessory muscles, or paradoxical breathing.
  • Hypercapnic Acidemia: Arterial pH <7.25 due to inadequate ventilation.
  • Airway Protection: Inability to clear secretions or protect the airway due to altered mental status.

Lung-Protective Ventilation Targets

  • Tidal Volume (Vₜ): Target 6 mL/kg of predicted body weight (PBW).
  • Plateau Pressure (Pₚₗₐₜ): Maintain ≤30 cm H₂O to minimize barotrauma.
  • Driving Pressure (ΔP): Keep below 15 cm H₂O (ΔP = Pₚₗₐₜ – PEEP), as this correlates strongly with mortality.
  • PEEP Titration: Use higher PEEP/FiO₂ tables to improve oxygenation while preventing alveolar collapse.

Adjunctive ARDS Therapies

  • Prone Positioning: For patients with a PaO₂/FiO₂ <150 mmHg, prone for at least 12-16 hours per day.
  • Neuromuscular Blockade: A continuous infusion (e.g., cisatracurium) for up to 48 hours may be considered for severe patient-ventilator dyssynchrony.
  • Venovenous ECMO: Reserved for refractory hypoxemia or uncompensated hypercapnia at experienced centers.
Pearl IconA shield with an exclamation mark. Clinical Pearl: Early Controlled Intubation

Delaying intubation can lead to patient self-inflicted lung injury (P-SILI) from high respiratory drive and large tidal volumes. Proactive, controlled intubation prevents this and avoids hemodynamic collapse that can occur during an emergent procedure.

Pearl IconA shield with an exclamation mark. Clinical Pearl: Timing of Prone Positioning

The survival benefit of prone positioning is greatest when initiated early, ideally within 36 hours of the onset of moderate-to-severe ARDS. It improves ventilation-perfusion matching and reduces lung stress.

2. Hemodynamic and Organ Support Monitoring

In septic shock, invasive monitoring and dynamic indices are crucial for guiding fluid management and detecting organ dysfunction, moving beyond reliance on static pressure measurements.

Arterial Pressure Monitoring

A radial arterial line is standard for continuous blood pressure monitoring and allows for frequent arterial blood gas sampling. The waveform itself provides clues: a steep upstroke with a low dicrotic notch may suggest vasodilation, while a narrow pulse amplitude points to low stroke volume.

Dynamic Fluid-Responsiveness Indices

These methods predict which patients will increase their stroke volume in response to a fluid bolus, helping to avoid harmful fluid overload.

  • Pulse Pressure Variation (PPV) & Stroke Volume Variation (SVV): In mechanically ventilated patients with no spontaneous breaths, a PPV >12% or SVV >10% suggests fluid responsiveness. These are unreliable in arrhythmias or with low tidal volumes.
  • Passive Leg Raise (PLR) Test: A temporary, reversible “autobolus” of ~300 mL of blood. An increase in stroke volume (measured by cardiac output monitor or echocardiography) of ≥10% strongly predicts fluid responsiveness.

Renal Monitoring and Renal Replacement Therapy (RRT)

  • Triggers for Concern: Oliguria (<0.5 mL/kg/h for >6 hours) or a rapid rise in serum creatinine are early signs of acute kidney injury (AKI).
  • Indications for RRT: Typically initiated for KDIGO stage 2–3 AKI with complications, such as severe metabolic acidosis, hyperkalemia, or significant volume overload refractory to diuretics.
  • Modality Choice: Continuous RRT (e.g., CVVH) is generally preferred over intermittent hemodialysis in hemodynamically unstable patients to ensure gentle fluid removal and better metabolic control.
Pearl IconA shield with an exclamation mark. Clinical Pearl: The Power of the PLR

The passive leg raise test is one of the most reliable dynamic indices because it is risk-free and can be repeated as needed. It provides a direct assessment of preload reserve without administering exogenous fluid.

3. Prevention of ICU-Related Complications

Prophylactic measures for venous thromboembolism (VTE), stress ulcers, and device-related infections are cornerstone interventions to limit ICU-acquired morbidity and improve outcomes.

Summary of Prophylactic Measures in Sepsis
Prophylaxis Type Primary Indication First-Line Agent Notes
VTE Prophylaxis Immobility + Sepsis-induced hypercoagulability Enoxaparin 40 mg SC daily Reduce to 30 mg for CrCl <30 mL/min. Use UFH if high bleed risk. Use mechanical compression if contraindicated.
Stress Ulcer Prophylaxis Mechanical ventilation >48h OR coagulopathy Pantoprazole 40 mg IV daily Reassess need daily. Discontinue when risk factors resolve to reduce risk of C. difficile and pneumonia.

Nosocomial Infection Prevention Bundles

  • Ventilator-Associated Pneumonia (VAP) Bundle:
    • Head-of-bed elevation to 30–45°
    • Daily sedation interruptions and spontaneous breathing trials
    • Oral care with chlorhexidine
    • Use of endotracheal tubes with subglottic secretion drainage
  • Central Line-Associated Bloodstream Infection (CLABSI) Bundle:
    • Strict hand hygiene and maximal barrier precautions during insertion
    • Skin antisepsis with chlorhexidine
    • Daily review of central line necessity with prompt removal when no longer needed
Pearl IconA shield with an exclamation mark. Clinical Pearl: The Impact of Bundles

Consistent adherence to care bundles has a profound impact on patient safety. Studies show that VAP and CLABSI bundles can reduce infection rates by approximately 40% and 60%, respectively. Daily evaluation prevents the unnecessary continuation of these measures once risk factors resolve.

4. Management of Iatrogenic Sequelae

Vigilant monitoring for drug-related organ dysfunction and ICU-acquired syndromes is essential to preserve long-term recovery potential.

A. Drug-Induced Organ Dysfunction

Monitoring for Common Drug Toxicities in the ICU
Drug Class Key Monitoring Parameter Mitigation Strategy
Aminoglycosides Trough level (<1 mg/L), Serum Creatinine Use extended-interval dosing (e.g., gentamicin 7 mg/kg).
Vancomycin AUC/MIC (target 400-600), Serum Creatinine Use AUC-guided dosing; consider continuous infusion for stable levels.
Amphotericin B Creatinine, Potassium, Magnesium Use liposomal formulations to reduce nephrotoxicity.
Propofol Triglycerides, Creatine Kinase (CK) Monitor for Propofol Infusion Syndrome; limit dose and duration.

B. Delirium and ICU-Acquired Weakness

The ABCDEF bundle is a evidence-based, multicomponent strategy to reduce delirium, improve pain management, and decrease long-term cognitive impairment.

ABCDEF Bundle for ICU Care A flowchart illustrating the six components of the ABCDEF bundle: Assess, Prevent & Manage Pain; Both Spontaneous Awakening & Breathing Trials; Choice of Analgesia & Sedation; Delirium: Assess, Prevent & Manage; Early Mobility & Exercise; and Family Engagement & Empowerment. A Assess, Prevent & Manage Pain B Both SAT & SBT (Awakening/Breathing) C Choice of Analgesia/Sedation D Delirium: Assess, Prevent & Manage E Early Mobility & Exercise F Family Engagement
Figure 1: The ABCDEF Bundle. A coordinated, interprofessional approach to critical care that has been shown to decrease ventilator time, reduce delirium, and improve survival.

5. Multidisciplinary Goals-of-Care and Palliative Integration

Early, structured discussions are critical to align high-intensity interventions with patient values, prevent nonbeneficial treatments, and support families.

Timing and Structure of Discussions

  • Initiate goals-of-care discussions within 72 hours of ICU admission.
  • Use clear, empathetic language to explain prognosis, likely outcomes (including functional status), and the burdens of continued treatment.
  • Document discussions and any advance directives (e.g., POLST, living will) clearly in the medical record.

Triggers for Palliative Care Consultation

  • Refractory shock or respiratory failure despite maximal medical therapy.
  • Progressive multi-organ failure with rising lactate (>4 mmol/L).
  • Underlying comorbidities that confer a limited life expectancy (<6 months).
Pearl IconA shield with an exclamation mark. Clinical Pearl: Benefits of Early Family Conferences

Proactive family meetings led by the multidisciplinary team not only improve family satisfaction and reduce psychological distress but have also been shown to reduce the length of stay in the ICU for patients who ultimately transition to comfort-focused care, ensuring that care aligns with patient and family goals.

References

  1. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49:e1063–e1143.
  2. Brower RG, Matthay MA, Morris A, et al; ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for ARDS. N Engl J Med. 2000;342:1301–1308.
  3. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on survival in acute respiratory failure. N Engl J Med. 2001;344:481–488.
  4. Frat JP, Thille AW, Mercat A, et al; FLORALI Study Group. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–2196.
  5. Russell JA, Walley KR, Singer J, et al; VASST Investigators. Vasopressin versus norepinephrine in septic shock. N Engl J Med. 2008;358:877–887.
  6. The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683–1693.
  7. Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809–818.
  8. Kellum JA, Angus DC, Johnson JP, et al. Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med. 2002;28:29–37.